Shahine A, Reinink P, Reijneveld J, Gras S, Holzheimer M, Cheng T, et al. A T-cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids. Nat Commun. 2019;10:56 pubmed publisher

Abalem M, Francischini S, Carricondo P, Graziano R. Fundus autofluorescence in Tay-Sachs disease. JAMA Ophthalmol. 2014;132:876 pubmed publisher

Krishnamoorthy K, Eichler F, Rapalino O, Frosch M. Case records of the Massachusetts General Hospital. Case 14-2014. An 11-month-old girl with developmental delay. N Engl J Med. 2014;370:1830-41 pubmed publisher

Kang S, Heo T, Kim S. Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells. Gene. 2014;539:181-5 pubmed publisher

Eggermont A, Suciu S, Rutkowski P, Marsden J, Santinami M, Corrie P, et al. Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial. J Clin Oncol. 2013;31:3831-7 pubmed publisher

Rupp A, Galban Horcajo F, Bianchi E, Dondi M, Penderis J, Cappell J, et al. Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. J Peripher Nerv Syst. 2013;18:75-88 pubmed publisher

Mardinoglu A, Agren R, Kampf C, Asplund A, Nookaew I, Jacobson P, et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol Syst Biol. 2013;9:649 pubmed publisher

Sinici I, Yonekawa S, Tkachyova I, Gray S, Samulski R, Wakarchuk W, et al. In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside. PLoS ONE. 2013;8:e57908 pubmed publisher

Yamaguchi T, Uno T, Uekusa Y, Yagi Utsumi M, Kato K. Ganglioside-embedding small bicelles for probing membrane-landing processes of intrinsically disordered proteins. Chem Commun (Camb). 2013;49:1235-7 pubmed publisher

Sargeant T, Drage D, Wang S, Apostolakis A, Cox T, Cachón González M. Characterization of inducible models of Tay-Sachs and related disease. PLoS Genet. 2012;8:e1002943 pubmed publisher

Liu F, Liu T, Qu M, Yang Q. Molecular and biochemical characterization of a novel ?-N-acetyl-D-hexosaminidase with broad substrate-spectrum from the Aisan corn borer, Ostrinia furnacalis. Int J Biol Sci. 2012;8:1085-96 pubmed

Kim C, Seo J, Cha H. Functional interaction analysis of GM1-related carbohydrates and Vibrio cholerae toxins using carbohydrate microarray. Anal Chem. 2012;84:6884-90 pubmed publisher

HOSHINO T, Uchiyama Y, Ito E, Osawa S, Ohashi T. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination. Intern Med. 2012;51:1595-8 pubmed

Pernber Z, Blennow K, Bogdanovic N, Mansson J, Blomqvist M. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease. Dement Geriatr Cogn Disord. 2012;33:174-88 pubmed publisher

Wilkinson F, Holley R, Langford Smith K, Badrinath S, Liao A, Langford Smith A, et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS ONE. 2012;7:e35787 pubmed publisher

Keilani S, Lun Y, Stevens A, Williams H, Sjoberg E, Khanna R, et al. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-? peptide. J Neurosci. 2012;32:5223-36 pubmed publisher

Dawson G, Fuller M, Helmsley K, Hopwood J. Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain. Neurochem Res. 2012;37:1372-80 pubmed publisher

Saito M, Chakraborty G, Shah R, Mao R, Kumar A, Yang D, et al. Elevation of GM2 ganglioside during ethanol-induced apoptotic neurodegeneration in the developing mouse brain. J Neurochem. 2012;121:649-61 pubmed publisher

Arthur J, Lee J, Snyder E, Seyfried T. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice. Neurochem Res. 2012;37:1335-43 pubmed publisher

Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, et al. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease. PLoS ONE. 2011;6:e29074 pubmed publisher

Nagahori N, Uchida M, Kinjo M, Yamashita T. Use of carbohydrate-conjugated nanoparticles for an integrated approach to functional imaging of glycans and understanding of their molecular mechanisms. Curr Pharm Biotechnol. 2012;13:2612-6 pubmed

Passos O, Fernandes P, Ramos M. QM/MM study of the catalytic mechanism of GalNAc removal from GM2 ganglioside catalyzed by human β-hexosaminidaseA. J Phys Chem B. 2011;115:14751-9 pubmed publisher

Klisch K, Contreras D, Sun X, Brehm R, Bergmann M, Alberio R. The Sda/GM2-glycan is a carbohydrate marker of porcine primordial germ cells and of a subpopulation of spermatogonia in cattle, pigs, horses and llama. Reproduction. 2011;142:667-74 pubmed publisher

Yamada T, Bando H, Takeuchi S, Kita K, Li Q, Wang W, et al. Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells. Cancer Sci. 2011;102:2157-63 pubmed publisher

Whitehead B, O Brien M, Jack B, Mitchell D. Experiences of dying, death and bereavement in motor neurone disease: a qualitative study. Palliat Med. 2012;26:368-78 pubmed publisher

Matsuoka K, Tsuji D, Taki T, Itoh K. Thymic involution and corticosterone level in Sandhoff disease model mice: new aspects the pathogenesis of GM2 gangliosidosis. J Inherit Metab Dis. 2011;34:1061-8 pubmed publisher

Smyth K, Fritzler M, Kirton A. Acquired infantile abducens palsy associated with anti-GM2 antibodies. Pediatr Neurol. 2011;44:459-62 pubmed publisher

Tetala K, Heikema A, Pukin A, Weijers C, Tio Gillen A, Gilbert M, et al. Selective depletion of neuropathy-related antibodies from human serum by monolithic affinity columns containing ganglioside mimics. J Med Chem. 2011;54:3500-5 pubmed publisher

Matsuoka K, Tamura T, Tsuji D, Dohzono Y, Kitakaze K, Ohno K, et al. Therapeutic potential of intracerebroventricular replacement of modified human ?-hexosaminidase B for GM2 gangliosidosis. Mol Ther. 2011;19:1017-24 pubmed publisher

Hovakimyan M, Stachs O, Reichard M, Mascher H, Lukas J, Frech M, et al. Morphological alterations of the cornea in the mouse model of niemann-pick disease type c1. Cornea. 2011;30:796-803 pubmed publisher

Fernández Marrero Y, Hernández T, Roque Navarro L, Talavera A, Moreno E, Griñán T, et al. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody. Mol Immunol. 2011;48:1059-67 pubmed publisher

Sorice M, Garofalo T, Misasi R, Dolo V, Lucania G, Sansolini T, et al. Glycosphingolipid domains on cell plasma membrane. Biosci Rep. 1999;19:197-208 pubmed

Nohara K, Wang F, Spiegel S. Glycosphingolipid composition of MDA-MB-231 and MCF-7 human breast cancer cell lines. Breast Cancer Res Treat. 1998;48:149-57 pubmed

Yohe H, Ye S, Reinhold B, Reinhold V. Structural characterization of the disialogangliosides of murine peritoneal macrophages. Glycobiology. 1997;7:1215-27 pubmed